Numans Health Food Holdings Co., Ltd. (Ticker: 2530 HK) is a China-based company specializing in the marketing, sales, and distribution of nutritional products. Established in 2019 and headquartered in Shanghai, the company's product portfolio includes algal oil DHA, probiotics, vitamins, multivitamins, and algal calcium, sold under proprietary brands. In 2022, Numans was the leading domestic brand in China’s algal oil DHA market, with a 22.5% market share by retail value, according to Frost & Sullivan.

The company will list on the Main Board of the Hong Kong Stock Exchange on January 10, 2025. Numans plans to offer 250 million shares globally, with an expected price range of HKD 0.80 to 1.09 per share, aiming to raise up to HKD 272.5 million (USD 35.1 million). A 15% greenshoe option equivalent to 37.5 million shares is included. The offering is managed by Caitong International Securities Co. Ltd., China Everbright Securities (HK), First Fidelity Capital International Ltd., and Futu Securities.

The proceeds from the IPO will be used to support product development, strengthen distribution networks, and enhance brand awareness within China's nutritional products market.